SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
191
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Agile Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 7, 2017 – AGRX

NEW YORK, Feb. 03, 2017 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:

To: All persons or entities who purchased or otherwise acquired securities of Agile Therapeutics, Inc. (“Agile Therapeutics”) (NASDAQ: AGRX ) between March 9, 2016 and January 3, 2017 . You are hereby notified that a securities class action lawsuit has been commenced in the USDC for the District of New Jersey. To get more information go to :

http://www.zlk.com/pslra/agile-therapeutics-inc

or contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

The complaint alleges that throughout the Class Period, Agile Therapeutics made materially false and/or misleading statements and/or failed to disclose that: (a) the Twirla contraceptive patch had an efficacy rating that fell below peer group standards; (b) over half of patients in its “Secure” Phase 3 Study discontinued the study early; and (c) the Twirla patch therefore allegedly had a slight chance of gaining approval by the U.S. Food and Drug Administration.

On January 3, 2017, Agile Therapeutics reported “positive top-line results” for the study, yet reported an efficacy measure that failed to meet the standard set by other approved contraceptive patches. In addition, more than 51% of subjects opted to discontinue the study. Upon this news, shares of Agile Therapeutics fell from a close of $5.70 per share on December 30, 2016, to a close of $2.63 per share on January 4, 2017.

If you suffered a loss in Agile Therapeutics you have until March 7, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation involving financial fraud, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:    Levi & Korsinsky, LLP Joseph E. Levi, Esq. 30 Broad Street - 24th Floor New York, NY 10004            Tel: (212) 363-7500 Toll Free:  (877) 363-5972 Fax: (212) 363-7171 www.zlk.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 344

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
Beko Pushes for Policy Synergy Amidst Carbon Shakeup

Updated Category News Views 176

When big names like Beko step up on the global stage, you pay attention. During the COP31 panels in Antalya, Türkiye, the company's brass made one thing clear: we need harmony in how climate, trade, and finance policies come together. The stakes? The very strength of industrial competitiveness as new carbon rules turn the heat up on manufacturing practices. The Call for...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 186

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 150

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
Motphys Unleashes MotrixSim 1.0, Aiming at Simulation Dominance

Updated Category News Views 234

Motphys Breaks into the Global Simulation Scene The tech world just got slammed with what might be a seismic shift: Motphys, a bold outfit hailing from China, has dropped its brand-new, homegrown simulation engine, MotrixSim 1.0. It's causing quite the stir, unveiling at the Conference on Robot Learning 2026 (CoRL) and throwing down the gauntlet to Western titans like...

Continue Reading
Layne's Chicken Fingers Expands with Brownsville Opening

Updated Category News Views 200

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 120

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 193

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
BETR's Slide: Investors Face Big Losses, Leadership Shift

Updated Category News Views 148

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 245

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading

Top 5 Most Recently Viewed Articles

Important Updates on Humacyte, Inc. Class Action Lawsuit

Updated Category News Views 122

Significant Legal Actions Involving Humacyte, Inc. Pomerantz LLP has announced an important class action lawsuit against Humacyte, Inc. (NASDAQ: HUMA), highlighting concerns regarding the conduct of the company's officers and directors. Shareholders who believe they have suffered losses are encouraged to review the specifics of this class action and consider their...

Continue Reading
Cuprina Holdings Takes Steps to Address Nasdaq Compliance Issues

Updated Category News Views 207

Cuprina Holdings Strives for Nasdaq Compliance Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) is a dedicated biomedical company focused on providing innovative solutions in chronic wound care, infertility, and cosmeceuticals. The company recently announced it received a notification from Nasdaq regarding its noncompliance with the minimum bid price requirement. This...

Continue Reading
Market Movers: Spotlight on Gap, Ross Stores, and More

Updated Category News Views 189

Exciting Market Updates to Watch As the U.S. stock futures show a slight decline this morning, attention is drawn to several noteworthy stocks making headlines today. Investors are keen to observe changes that might signal evolving market trends. Destination XL Group, Inc Earnings Preview Destination XL Group, Inc (NASDAQ: DXLG) is anticipated to announce its quarterly...

Continue Reading
Coca-Cola's Barrilitos Relaunch Brings Tradition Back to Life

Updated Category News Views 503

Coca-Cola's Barrilitos Relaunch: A Journey Through Flavor Barrilitos Made Con Mucho Flavor connects consumers to the generations that came before them. The Coca-Cola Company is thrilled to announce the highly anticipated relaunch of Barrilitos, an esteemed Mexican soft drink with a timeless legacy that began in 1938. This beverage has now been added to Coca-Cola's imports...

Continue Reading
374Water Takes Major Stride in PFAS Destruction Technology

Updated Category News Views 152

374Water's Innovative Approach to PFAS Destruction 374Water Inc. (NASDAQ: SCWO), a prominent player in clean technology solutions, is set to showcase its groundbreaking AirSCWO technology in a pivotal Department of Defense (DoD) project. The initiative aims to develop commercial-scale strategies to effectively manage per- and polyfluoroalkyl substances (PFAS), commonly...

Continue Reading